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is diminished, limiting the potency of
T cells to enter skin sites. On the other
hand, the decrease in Treg markers
might be the result of decreased in-
flammation, and together with the
persistent decreased expression of
A20/TNF–AIP3 might be important for
the only transient improvement often
seen after CsA treatment.
The study was approved by the
local ethics committee and patients
gave their written informed consent.
This study was conducted accord-
ing to the Declaration of Helsinki
Principles.
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TO THE EDITOR
Epidermal melanocytes (MCs) are
specialized melanin-producing cells
(Slominski et al., 2004; Yamaguchi
et al., 2007; Thomas and Erickson,
2008; Park et al., 2009) that synthesize
melanin within the melanosome
(Slominski et al., 2004) and protect
individuals from harmful UV rays
(Slominski et al., 2004; Yamaguchi
et al., 2007; Thomas and Erickson,
2008; Park et al., 2009). Defects in or
a lack of MCs can lead to melanoma,
pigment disorders, and auditory de-
fects. MC proliferation and differentia-
tion in skin is tightly linked to hair
regeneration cycles. MCs in vertebrates
are derived from neural crest (Thomas
and Erickson, 2008). In hair follicles,
melanoblasts are segregated into hair
matrix MCs (for hair pigmentation) and
melanocyte stem cells (MCSCs). The
discovery of MCSCs and induced plur-
ipotent (iPS) cells provides important
resources to elucidate mechanisms
underlying melanogenesis and patho-
genesis of MC-related disorders (Lin
and Chuong, 2011; Nishikawa-Torikai
et al., 2011; Nishimura, 2011; Ohta
et al., 2011; Yang et al., 2011).
Although MCSCs and iPS cells are
important MC precursors for mechan-
istic studies, their isolation and expan-
sion are technically challenging.
Here we investigate whether MCs
can be immortalized without com-
promising melanogenic potential. By
using primary MCs isolated from
newborn mouse skin, we engineered
4100 clones by introducing SV40 T
antigen (SV40T), which is flanked with
FRT sites (Supplementary Figure S1A
online; Westerman and Leboulch,
1996). We found that although primary
MCs grew slower after passage 5
immortalized MC (iMC) cells acquired
Abbreviations: FLP, flippase recombination enzyme; GFP, green fluorescent protein; GLuc, Gaussia
luciferase; iMC, immortalized melanocyte; iPS, induced pluripotent; MCSC, melanocyte stem cell;
TRP-1, tyrosinase-related protein 1
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high proliferative activity (Supple-
mentary Figure S1B online); how-
ever, wide variations in proliferation
were observed among clones. For ins-
tance, iMC23 grew faster than iMC65
(Figure 1a).
We analyzed melanogenic markers in
iMC clones. More than half of the
analyzed clones expressed progenitor
marker c-kit, whereas MC progenitor
markers Pax3, Sox10, and MITF-m were
readily detected in most clones (Supple-
mentary Figure S2A online). Dopachrome
tautomerase and tyrosinase-related pro-
tein 1 (TRP-1) were highly expressed
in most iMC clones, whereas tyrosinase
was highly expressed in about half of
the clones (Supplementary Figure S2B
and C online). It is conceivable that early
melanogenic iMCs should express c-kit
and early melagonic markers but not late
markers (e.g., tyrosinase). Three iMC
clones were chosen for further characteri-
zation: iMC23 (melanoblast progenitor-
like) (Figure 1aA), iMC65 (late-stage
melanocyte-like) (Figure 1aB), and
iMC37 (intermediately differentiated
melanoblast-like). These results indi-
cate that SV40T-mediated immortaliza-
tion can create a repertoire of iMCs
with varied melanogenic potential.
We also tested whether immortaliza-
tion phenotypes were reversible by
flippase recombination enzyme (FLP).
By using adenovirus FLP (AdFLP) that
co-expresses green fluorescent protein
(GFP; He et al., 1998; Luo et al., 2007),
we found that iMCs were effectively
transduced by AdFLP or AdGFP, and
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Figure 1. Characterization of SV40T-immortalized melanocytes (iMCs). (a) iMC23 (aA) and iMC65 (aB) were seeded at low density and photographed at day 5.
(bA) iMCs were infected with AdGFP or AdFLP. Green fluorescent protein signal was detected at 24 hours. (bB) iMCs were infected with AdFLP (þ )
or AdGFP () for 48 hours. Total cellular proteins were analyzed by anti-SV40T western blotting (b-actin blotting for loading). (bC, bD) iMC23 cells
were infected with AdFLP or AdGFP, stained with Crystal violet, and the absorbance was quantitatively measured at 560 nm. (cA) iMCs were collected
by pelleting. Pigmentation of cell pellets was photographed. (cB) iMCs were collected for endogenous tyrosinase enzymatic assays. (dA) iMCs were
immunostained with c-kit and HMB45 antibodies. (dB) iMCs were subjected to Fontana–Masson staining of melanin (arrows). OD, optical density.
Bar¼50 mm.
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SV40T expression was reduced in FLP-
transduced iMCs (Figure 1bA and bB).
iMC23 infected with AdFLP grew
slower (Figure 1bC and bD), suggesting
that the proliferative activity of iMCs
may be reversed by removing SV40T.
By using reporter pTyr-Gluc-expressing
Gaussia luciferase (GLuc) driven by a
2.0-kb mouse tyrosinase promoter,
we found that GLuc activity was
increased by dexamethasone and was
potentiated by removing SV40T with
FLP (Supplementary Figure S3A and B
online).
We further analyzed spontaneous
differentiation of iMCs by assessing
endogenous melanin and tyrosinase
activity. Cell pellets from iMCs exhib-
ited varied amounts of melanin. iMC65
and iMC61 exhibited the highest level
of melanin and iMC23 produced the
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Figure 2. Melanogenic potential of immortalized melanocytes (iMCs). (aA) iMC23 cells were treated with dexamethasone (Dex) for 5 days and collected
for tyrosinase enzymatic assay. (aB) iMC23 was stimulated with 12 nM Dex. Gene expression was determined by reverse transcriptase–PCR (RT-PCR;
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as control). (b) iMC23 was treated with 12 nM Dex for 5 days. Melanin production was visualized (bA)
in cell pellet, (bB) in culture under the microscope, or by (bC) Fontana–Masson staining. Melanin-positive cells are indicated with arrows. Bar¼ 100 mm.
(cA) Luciferase-tagged iMC23 and iMC65 infected with AdFLP or AdGFP were injected subcutaneously into flanks of athymic mice (arrows) and subjected
to Xenogen imaging. (cB) Visual pigmentation at injection sites (arrows). (d) Injected sites were retrieved at day 7 and subjected to (dA) HMB45 immunostaining
(HRP-AEC) and (dB) Fontana–Masson staining. Melanin-positive cells are indicated with arrows. Bar¼ 25 mm.
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lowest level, whereas a majority of iMC
clones produced low-to-modest levels
of melanin (Figure 1cA). Accordingly,
quantitative analysis revealed that
iMC65 and iMC61 exhibited high
tyrosinase activity, and seven clones
including iMC23 had low tyrosinase
activity, whereas iMC37 exhibited
modest-to-high levels of tyrosinase ac-
tivity (Figure 1cB), consistent with the
qualitative results shown in Figure 1cA.
We characterized the early and late
markers c-kit and HMB45, respectively,
in iMC23, iMC37, and iMC65. HMB45
is a widely used mAb detecting
melanocytic tumors (Gown et al.,
1986). iMC23 expressed a high level
of c-kit, whereas iMC37 and iMC65
were strongly stained with HMB45
(Figure 1dA). Fontana–Masson staining
revealed the highest level of melanin in
iMC65 and a modest level in iMC37,
whereas a negligent level of melanin
was observed in iMC32 (Figure 1dB).
Thus, these clones may represent differ-
ent stages of melanogenic differentiation.
We further analyzed the melanogenic
potential of iMC23. When iMC23 was
treated with dexamethasone, tyrosinase
activity increased in a dose-dependent
manner (Figure 2aA). Dexamethasone
induced tyrosinase and TRP-1 expression
(Figure 2aB). Dose-dependent melanin
production was visible in culture and
cell pellet (Figure 2bA and bB), which
was further confirmed by Fontana–
Masson staining (Figure 2bC). These
results indicate that iMC23 exhibits
melanogenic potential.
Finally, we determined whether iMC
immortalization phenotypes were rever-
sible in vivo. iMC23 and iMC65 tagged
with firefly luciferase were infected with
AdFLP or AdGFP, collected for subcuta-
neous injection into athymic mice, and
monitored by Xenogen bioluminescence
imaging (Caliper Life Sciences, Hopkin-
ton, MA). AdGFP-transduced iMC23
yielded a stronger signal than that of
AdFLP-transduced iMC65, whereas with-
in the same lines AdFLP-transduced cells
produced no signal compared with the
AdGF-transduced iMC65 (Figure 2cA),
suggesting that removing SV40T may
reduce proliferation and survival of iMCs
in vivo. Pigmentation of injected iMCs
was visible through skin, as iMC65
exhibited a higher level of pigmenta-
tion than iMC23. AdFLP-transduced
iMC23 yielded more pigmentation than
AdGFP-transduced iMC23 (Figure 2cB).
Histologically, iMC23 injection sites
had higher cellularity than iMC65 sites,
whereas in both lines cellularity was
lower in AdFLP-transduced cells (Sup-
plementary Figure S3C online). Produc-
tion of melanin was more pronounced
in AdFLP-transduced iMCs as indicated
by HMB45 immunostaining and Fontana–-
Masson staining (Figure 2dA and dB).
Overall, the in vivo results are consistent
with these clones’ in vitro features.
SV40T-immortalized MCs are non-
tumorigenic under our experimental
conditions. Interestingly, melanoma phe-
notypes have been reported by enabling
neoplastic transformation of primary hu-
man MCs with SV40 early region, which
encodes both SV40 T and t antigens, in
conjunction with hTERT (Gupta et al.,
2005). Nevertheless, we established a
repertoire of conditionally immortalized
MCs with varied melanogenic potential,
ranging from melanoblast-like to well-
differentiated phenotypes. Such reper-
toire of iMCs should be useful for
understanding MC biology and raveling
molecular pathogenesis of pigment cell
disorders, including melanoma.
An efficient method to isolate and
expand cutaneous MCs is needed, as
it enables us to better understand mela-
nogenesis. Here we demonstrate that
SV40T-mediated immortalization of MCs
is simplistic, effective, and reversible.
This approach should be considered
an important alternative to the isolation
and characterization of melanogenic
stem cells.
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